Back to LCTX
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC → LCTX
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
5
Latest value
$11M
Q3 2026
Peak value
$12.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $469K |
| Q4 2025 | $3.4M |
| Q1 2026 | $5.8M |
| Q2 2026 | $12.1M |
| Q3 2026 | $11M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $11M | 320.7K | — | — |
| Q2 2026 | $12.1M | 288.0K | — | — |
| Q1 2026 | $5.8M | 175.7K | — | — |
| Q4 2025 | $3.4M | 93.0K | — | — |
| Q3 2025 | $469K | 11.7K | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M